Bull Run

Advanced stock screening and portfolio analysis for Indian equity markets.

Navigation

Tools & Features

  • Premium Features
© 2025 Bull Run. All rights reserved.
info@bullrun.co.in

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities. Bull Run is not a SEBI-registered Research Analyst/Investment Adviser.

HomeStocksDiversified Commercial ServicesZenlabs Ethica Ltd

Zenlabs Ethica Ltd Stock Price Today (NSE: ZENLABS)

Zenlabs Ethica Ltd

ZENLABSDiversified Commercial Services
₹19.90+₹0.00 (+0.00%)↑
As on 19 Feb 2026, 10:31 am ISTMarket Closed

Fundamental Score

...

Zenlabs Ethica Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis

Zenlabs Ethica Ltd share price today is ₹19.90, up +0.00% on NSE/BSE as of 19 February 2026. Zenlabs Ethica Ltd (ZENLABS) is a Small-cap company in the Diversified Commercial Services sector with a market capitalisation of ₹18.57 (Cr). The 52-week high for ZENLABS share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 74.28x, ZENLABS is currently trading above its industry average P/E of 23.64x. The company has a Return on Equity (ROE) of 2.63% and a debt-to-equity ratio of 0.93.

Zenlabs Ethica Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
+0.00%

Returns & Performance

Poor

ROE

2.63%
Poor

ROCE

5.69%
Poor

OPM (5Y)

3.98%

Div Yield

0.00%

Zenlabs Ethica Ltd Valuation Check

Poor

P/E Ratio

74.28x
Poor

Industry P/E

23.64x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

18.57 (Cr)

Growth Engine

Poor

Profit Growth (Q)

-20.00%
Poor

Sales Growth (Q)

-6.89%
Poor

Sales Growth (5Y)

-2.55%
Excellent

EPS Growth (5Y)

18.84%
Excellent

Profit Growth (5Y)

18.84%

Balance Sheet Health

Poor

Debt to Equity

0.93x
Poor

Int. Coverage

1.47x

Free Cash Flow (5Y)

-13.91 (Cr)

Shareholding

Excellent

Promoter

52.96%
Poor

FII

0.00%
Poor

DII

0.00%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Zenlabs Ethica Share Price: A Conservative Value Investor's Perspective

In the fragmented and highly competitive diversified commercial services sector, maintaining profitability and building a sustainable moat presents significant challenges. This analysis examines the "Zenlabs Ethica share price" through the lens of a conservative value investor, prioritizing capital safety above all else. Currently trading at ₹19.030001, the stock's attractiveness hinges on a careful evaluation of its financial metrics and competitive positioning.

The most immediate concern is Zenlabs Ethica's PE ratio of 74.28. This suggests the market has high expectations for future earnings growth, expectations that need to be realistically assessed. A high PE, in isolation, isn't inherently negative, but it amplifies the risk if the company fails to deliver. We need to dig deeper into their financials to ascertain if such a high multiple is justified by sustainable earnings potential.

Furthermore, the Return on Capital Employed (ROCE) of 5.69% is a red flag for a value investor. A low ROCE indicates that the company is not efficiently generating profits from its capital investments. This severely impacts the company's ability to build an economic moat, as reinvesting earnings at such low returns hinders long-term value creation and competitive advantage. A weak moat leaves Zenlabs Ethica vulnerable to competitive pressures and pricing wars within the diversified commercial services industry.

Comparing Zenlabs Ethica Ltd with peers such as Nirmitee Robotics India Ltd could reveal interesting management quality differences. While a direct comparison of operational strategies is impossible without deep dives into both companies' management actions, the ROCE differences could be indicative. Nirmitee's management actions in capital allocation can be reviewed independently for comparison.

This analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. It's crucial to understand that this is an observational analysis of publicly available information and should not be construed as investment advice. A thorough understanding of Zenlabs Ethica's business model, competitive landscape, and financial health is necessary before making any investment decisions. Further research is required to determine if the current Zenlabs Ethica share price offers an adequate margin of safety for a conservative value investor.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Zenlabs Ethica Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ZENLABS across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Excellent EPS Growth (18.84% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (18.84% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Balanced Promoter Holding (52.96%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

10 factors identified

Below-Average Return on Equity (2.63%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (5.69%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (3.98%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 74.28x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-20.00%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-6.89%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Limited Growth History (-2.55% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Interest Coverage (1.47x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-13.91 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Zenlabs Ethica Ltd Financial Statements

Comprehensive financial data for Zenlabs Ethica Ltd including income statement, balance sheet and cash flow

About ZENLABS (Zenlabs Ethica Ltd)

Zenlabs Ethica Ltd (ZENLABS) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Diversified Commercial Services sector with a current market capitalisation of ₹18.57 (Cr). Zenlabs Ethica Ltd has delivered a Return on Equity (ROE) of 2.63% and a ROCE of 5.69%. The debt-to-equity ratio stands at 0.93, reflecting the company's capital structure. Investors tracking ZENLABS share price can monitor key metrics including P/E ratio, promoter holding of 52.96%, and quarterly earnings growth.

Company Details

Symbol:ZENLABS
Industry:Diversified Commercial Services
Sector:Diversified Commercial Services
Website:https://www.zenlabsethica.com

Key Leadership

Mr. Sanjeev Kumar Singal
Chairman of the Board, CEO & MD
Mr. Adarsh Sharma
Chief Financial Officer
Mr. Sanjay Dhir
Executive Whole Time Director

Corporate Events

Recent
Ex-Dividend Date
2022-07-29

Latest News

Zenlabs Ethica Ltd Falls to 52-Week Low Amidst Continued Downtrend - Markets Mojo
Markets Mojo• 12/30/2025
Will Zenlabs Ethica Limited Benefit From Broader Market Bounce - Volume Weighted Average Price & High Yield Investment Portfolio - bollywoodhelpline.com
bollywoodhelpline.com• 12/27/2025
Zenlabs Ethica Limited Inches Toward Key Resistance — Will It Break - Stock Price Forecasts & High Profit Market Growth - bollywoodhelpline.com
bollywoodhelpline.com• 12/26/2025

ZENLABS Share Price: Frequently Asked Questions

What is the current share price of Zenlabs Ethica Ltd (ZENLABS)?

As of 19 Feb 2026, 10:31 am IST, Zenlabs Ethica Ltd share price is ₹19.90. The ZENLABS stock has a market capitalisation of ₹18.57 (Cr) on NSE/BSE.

Is ZENLABS share price Overvalued or Undervalued?

ZENLABS share price is currently trading at a P/E ratio of 74.28x, compared to the industry average of 23.64x. Based on this relative valuation, the Zenlabs Ethica Ltd stock appears to be Overvalued against its sector peers.

What is the 52-week high and low of ZENLABS share price?

The 52-week high of ZENLABS share price is ₹N/A and the 52-week low is ₹N/A.

What factors affect the Zenlabs Ethica Ltd share price?

Key factors influencing ZENLABS share price include quarterly earnings growth (Sales Growth: -6.89%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Zenlabs Ethica Ltd a good stock for long-term investment?

Zenlabs Ethica Ltd shows a 5-year Profit Growth of 18.84% and an ROE of 2.63%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.93 before investing in ZENLABS shares.

How does Zenlabs Ethica Ltd compare with its industry peers?

Zenlabs Ethica Ltd competes with major peers in the Diversified Commercial Services. Investors should compare ZENLABS share price P/E of 74.28x and ROE of 2.63% against the industry averages to determine competitive standing.

What is the P/E ratio of ZENLABS and what does it mean?

ZENLABS share price has a P/E ratio of 74.28x compared to the industry average of 23.64x. Investors pay ₹74 for every ₹1 of annual earnings.

How is ZENLABS performing according to Bull Run's analysis?

ZENLABS has a Bull Run fundamental score of 21.2/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does ZENLABS belong to?

ZENLABS operates in the Diversified Commercial Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Zenlabs Ethica Ltd share price.

What is Return on Equity (ROE) and why is it important for ZENLABS?

ZENLABS has an ROE of 2.63%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Zenlabs Ethica Ltd generates profits from shareholders capital.

How is ZENLABS debt-to-equity ratio and what does it indicate?

ZENLABS has a debt-to-equity ratio of 0.93, which indicates moderate leverage that should be monitored.

What is ZENLABS dividend yield and is it a good dividend stock?

ZENLABS offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Zenlabs Ethica Ltd shares.

How has ZENLABS share price grown over the past 5 years?

ZENLABS has achieved 5-year growth rates of: Sales Growth -2.55%, Profit Growth 18.84%, and EPS Growth 18.84%.

What is the promoter holding in ZENLABS and why does it matter?

Promoters hold 52.96% of ZENLABS shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Zenlabs Ethica Ltd.

What is ZENLABS market capitalisation category?

ZENLABS has a market capitalisation of ₹19 crores, placing it in the Small-cap category.

How volatile is ZENLABS stock?

ZENLABS has a beta of N/A. A beta > 1 suggests the Zenlabs Ethica Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is ZENLABS operating profit margin trend?

ZENLABS has a 5-year average Operating Profit Margin (OPM) of 3.98%, indicating the company's operational efficiency.

How is ZENLABS quarterly performance?

Recent quarterly performance shows Zenlabs Ethica Ltd YoY Sales Growth of -6.89% and YoY Profit Growth of -20.00%.

What is the institutional holding pattern in ZENLABS?

ZENLABS has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Zenlabs Ethica Ltd stock.

HomeScreenerBattleWatchlist